SCHEMBL8153263

SCHEMBL8153263

Oc1ccc(N2CCN(c3ccc(N4CCN(c5ccc(O)cc5)CC4)c4nonc34)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.51
ALDH1A1 P00352 8/20 0.51
MEN1 O00255 8/20 0.51
KMT2A Q03164 8/20 0.51
GAA P10253 8/20 0.51
THRB P10828 3/20 0.51
RECQL P46063 2/20 0.51
BLM P54132 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 2/20 0.51
TDP2 O95551 1/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
KDM4E B2RXH2 3/20 0.46
PKM P14618 1/20 0.46
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5367281 0.84 MEN1 (0.54) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL7041242 0.77 MAPT (0.68) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL5294666 0.71 MEN1 (0.70) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL7106841 0.71 KDM4E (0.61) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL7334978 0.70 CHKA (0.61) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL5371333 0.70 MEN1 (0.54) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL3713633 0.69 MEN1 (0.71) MAPTALDH1A1MEN1KMT2ATHRB
SCHEMBL2478090 0.69 PRKDC (0.58) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL8931737 0.69 DRD4 (0.67) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL5242737 0.68 MEN1 (0.70) MAPTALDH1A1MEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008115259-A2 DERIVATIVES OF BENZOXADIAZOLE SUITABLE FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES RIGEL PHARMACEUTICALS, INC. (US) 2008-09-25 WO disclosed